Weill Cornell Medicine Gets Grant for Breast Cancer Liquid Biopsy
A new test uses AI to see whether a patient is positive for cancer as soon as detectable by mammogram or earlier, and before symptoms arise.
Read MorePosted by Andy Lundin | Jan 3, 2024 | Breast |
A new test uses AI to see whether a patient is positive for cancer as soon as detectable by mammogram or earlier, and before symptoms arise.
Read MorePosted by Chris Wolski | Dec 26, 2023 | Blood Gas Analyzers |
Inspira Technologies has announced an advancement in its sensor technology with its HYLA Blood Sensor, which has achieved 95% accuracy.
Read MorePosted by Andy Lundin | Dec 7, 2023 | Hematology Instrumentation |
The hematology analyzer provides patient-side results to screen for conditions including infection, leukemia, and other blood-related cancers.
Read MorePosted by Andy Lundin | Dec 4, 2023 | Lab Automation, Unknown Origin & Other Cancer Types |
Beckman Coulter Life Sciences received 510(k) clearance from the FDA to distribute its AQUIOS STEM System in the United States.
Read MorePosted by Andy Lundin | Nov 17, 2023 | Transfusion & Transplantation Tests |
Verici Dx signed a licensing agreement with Thermo Fisher on an assay for pre-transplant prognostic testing of early kidney rejection risks.
Read More